Analysen von Richard Vosser
| 18.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 14.02.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.02.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 10.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 27.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 14.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 10.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 19.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.11.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |